Marisa Cabeza has been Researcher and Professor at the Universidad Autónoma Metropolitana-Xochimilco since 1976. She was born in Mexico City, where she got her Ph.D. degree in basic biomedical research in 1995 at the Universidad Nacional Autónoma de México in Mexico City. Since 1972, Professor Cabeza has been Postgraduate Professor in biochemistry, biomedical sciences, physiology, and other disciplines related to medical sciences at the Universidad Nacional Autónoma de México and at the Universidad Autónoma Metropolitana. She began her research work as a Research Assistant in the field of hormones in 1972 at the Instituto Nacional de Enfermedades de la Nutrición Salvador Zubirán, later to become the Head of research on steroidal hormones at the Universidad Autónoma Metropolitana. Her work has been recognized by Conacyt, which named her National Researcher of level II in the National System of Researchers in Mexico. She is the author of many publications in international journals, of two books, as well as of many book chapters related to hormones. She obtained a patent related to the production of antiacne ointment that contains steroidal hormones. Dr. Cabeza has directed “Licenciatura,” Master's, and Ph.D. theses at the Universidad Nacional Autónoma de México and at the Universidad Autónoma Metropolitana. In 1984, she was awarded the Prize for the Best Contribution to Pharmacy by the Mexican Pharmaceutical Association. In 2003, she was awarded the Prize for the Best contribution to Urology and Nephrology by the National Hospital of México. She is a Member of the Western Pharmacology Society and the Asociación Mexicana de Bioquímica Clínica. At the moment, she is a Member of the Biological Systems Department at the Universidad Autónoma Metropolitana-Xochmilco as a Full Professor and Researcher and has focused her research in the field of the biological effects of new steroidal compounds which have been synthesized by the group which Dr. Cabeza codirects. This research has the aim to find molecules with potential therapeutical use as antiandrogens, to improve diseases such as benign prostatic hypertrophy and prostate cancer.
Biography Updated on 3 April 2011